Former HHS No. 2 would bring extensive knowledge of the sprawling department and policy expertise in the drug pricing area, where the Trump Administration is readying new actions.
On Oct. 30, Ranking Democrats on the Senate HELP and Finance Committees Patty Murray and Ron Wyden, respectively, sent a letter to President Trump that included a list of 51 policies and ideas that any nominee for HHS Secretary would be “expected” to support.
Murray and Wyden vowed to “closely scrutinize” any nominee to replace Tom Price to ensure they “champion” a range of...
The inclusion of investigational drugs in the Critical Medicines Act and new provisions on stockpiling are among the raft of amendments the European Parliament has made to the draft legislation.
A meeting between the European Commission and industry stakeholders has revealed several areas of importance and lessons learned in relation to the EU Health Technology Assessment Regulation, which began to apply to certain medicinal products this year.
The US FDA’s unprecedented publication of 89 recent CRLs for unapproved products comes with a promise to release future letters more promptly.
